Navigation Links
The EntreTech Forum Presents... Greening Of America - The Conversion of Bio-Agriculture, Bio-Energy, and Bio-Products to Eco-Sustainable Businesses

BOSTON, Jan. 30 /PRNewswire/ -- At The EntreTech Forum's February 17th meeting, the panel of business, technology and investment professionals - all contributors, supporters and participants in the emerging bio-economy - will emphasize businesses and technologies that present eco-sustainable activities for this "Triple Bio" play of bio-agriculture, bio-energy, and bio-products.

Last summer we saw the impact of peaking global production of fossil hydrocarbons in the massive price increase for our fuels. Even more devastating was the impact to the agriculture sector for food production, processing and transportation.

A Bio-Economy is emerging with bio-agriculture, bio-energy, bio-products taking on new emphasis in our national quest for energy independence and sustainability.

As Chad Kruger of Washington State University identified, this "Triple Bio" involves three interwoven tracks of:

  • bio-agriculture to produce food and feedstock in an environmentally and energetically sustainable way. It is a suite of concepts, practices and technologies which capitalize on biological processes to maximize resource conservation and resource-use.

  • bio-products research and development to process raw biological feedstock into useful and higher value materials. This refers to refined, value-added materials derived from biomass, such as industrial, biological, medical and nutraceutical products.

  • bio-energy to reduce our reliance on fossil fuels for transportation fuels, electricity and heat. It refers to both power (electricity and heat) and liquid fuels derived from biomass.

       Tuesday, February 17, 2009  6:30 - 9:30 p.m.

       The Enterprise Center at Foley Hoag,
       The Bay Colony Corporate Center
       1000 Winter St., Ste. 4000
       Waltham, MA
       Cost: $25. public  $10. students & active military

For information, registration and directions visit our web site

Pre-Registration Available Online

Directions & Map


Meeting Organizers:

About The EntreTech Forum

The EntreTech Forum consists of moderated monthly panel discussions on emerging academic research and the commercialization of this technology. It was designed for those interested in technology innovation and marketing collaboration and networking with fellow entrepreneurs, business and government executives, investors, and technology researchers.

The technology-innovation presentations feature entrepreneurial and corporate accomplishments along commercialization pathways with discussions of tech transfer and technology incubation and research from universities, industry and government. The multi-disciplinary subjects of raising and utilizing different forms of capital, building alliances and structuring deals are included as part of the programming, and serve as tools for the entrepreneur and researcher to commercialize science and technology.

The EntreTech Forum is an affiliate of Northeastern University's School of Technological Entrepreneurship (STE) and is directed by a governing board of business principals, investors, and researchers.

For information and directions visit our web site at

CONTACT: Lawrence C. Grumer, Forum Chairman of The EntreTech Forum, +1-617-325-9852, e-Fax, +1-484-303-9852,

Web site: /

SOURCE The EntreTech Forum
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Novavax CMO to Present at Phacilitate Vaccine Forum Washington 2009
2. ImmunoVaccine Technologies Presents at OneMed Place Finance Forum
3. Victhom to Participate in the OneMedPlace Finance Forum
4. GeneNews to exhibit ColonSentry(TM) at Family Medicine Forum 2008
5. Cadient Groups GEL Interactive Technologies to Present and Exhibit at CBIs 5th Annual Forum
6. InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum
7. Novavax CEO to Present at BIO Investor Forum 2008
8. Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008
9. Nile Therapeutics to Present at the 7th Annual BIO Investor Forum
10. Neurobiological Technologies to Present at the BIO Investor Forum in San Francisco on October 30, 2008
11. Gerson Lehrman Group and BIO Collaborate to Identify Scientific Expertise for the Seventh Annual BIO Investor Forum
Post Your Comments:
(Date:10/8/2015)... Fla. , Oct. 8, 2015   Intrexon ... synthetic biology, today announced the appointment of Joseph ... Environment Sector, succeeding Nir Nimrodi who continues ... Vaillancourt will direct Intrexon,s endeavors to generate sustainable, biologically ... America , where he held a variety of ...
(Date:10/8/2015)... IRVINE, Calif. , Oct. 8, 2015 ... announced its expansion into the North American market with ... Asia and Europe ... a pioneer of Target Enrichment methodology and sample preparation ... or NGS, facilitates both hereditary and somatic genetic testing ...
(Date:10/8/2015)... -- The ALS Association, in partnership with Prize4Life, is pleased ... communication technology solutions for people living with ALS. ... lateral sclerosis) is a progressive neurodegenerative disease that affects ... cord. Eventually, people with ALS lose the ability to ... total paralysis and death within two to five years ...
(Date:10/8/2015)... ... 08, 2015 , ... ProMIS Neurosciences, Inc. (TSX: PMN), announced ... commercialize intellectual property rights belonging to The University of British Columbia (UBC). This ... worldwide rights to intellectual property based on use of the ProMIS™ technology, modifications ...
Breaking Biology Technology:
... Sept. 23 S*BIO Pte Ltd today announced ... will support the continued development of S*BIO,s clinical ... reflects the international investment community,s strong interest in ... clinical development and the quality of our various ...
... China, Sept. 22 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, ... ), which develops, manufactures, and markets specialty pharmaceutical ... has successfully completed Phase I clinical trials of ... Cephalosporin continues to be the most widely prescribed ...
... VANCOUVER, Sept. 22 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ... of results from a randomized Phase 2 trial ... results showed a survival benefit with the investigational ... cancer. The median overall survival for patients who ...
Cached Biology Technology:
(Date:10/6/2015)... Oct. 6, 2015  Maverix Biomics, Inc., a ... to its software portfolio with the debut of ... differential expression in eukaryotes. The software is integrated ... cloud-based genomic analysis solution that leverages proven open-source ... next-generation sequencing efforts. Garry Nolan,s ...
(Date:9/30/2015)... , Sept. 30, 2015  With nearly 300,000 Americans ... of new SCIs estimated to reach 12,500 annually, the ... California Resource Services for Independent Living (SCRS-IL) is ... California opening doors to independence ... programs and services, notably assistive technology services and education. ...
(Date:9/29/2015)... is excited to be named one of the first 100 ... announcement was recently made at an invite-only IBM Watson: ... Francisco , where iDAvatars presented a demo of its ... "It is both an honor and a privilege to be ... the cognitive power of IBM Watson in our product, which ...
Breaking Biology News(10 mins):
... RIVERSIDE, Calif. With the Easter holiday season coming up ... hens in egg farms producing the maximum number of eggs they ... can reduce egg production by five percent or more," says ... the University of California, Riverside. "One way to boost egg ...
... 2011 Stanford University professor Axel T. Brunger has ... Biochemistry and Molecular Biology,s inaugural DeLano Award for Computational ... Structural Biology with Single Molecules" at 9:03 a.m. on ... at the Walter E. Washington Convention Center in Washington, ...
... Mass. A single change to even one of the ... the human genome can result in severe diseases such as ... minor change in the DNA of a virus or bacteria ... for physicians to treat with standard drug therapies. For these ...
Cached Biology News:
Goat polyclonal to XAGE1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGFGFRRQGEDNT, corresponding to C terminal amino acids 149-160 of Human XAGE1 Entrez Gene ID: 9...
Synaptotagmin, phosphoSer309...
... anti-phospho-PTEN (Ser385) ... amino acid region encompassing the ... (Ser385), Accession ... Quality Assurance: Routinely ...
Allophycocyanin (APC) anti-human CD193 (CCR3, CKR3) 25 tests...
Biology Products: